Applied Therapeutics, Inc. — Director's Dealing 2023

Dec 23, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Applied Therapeutics Inc. (APLT)
CIK: 0001697532
Period of Report: 2023-12-21

Reporting Person: Shendelman Shoshana (Director, President and CEO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-12-21	Common Stock	A	1100000	$0.00	Acquired	3696387	Direct
2023-12-21	Common Stock	A	440000	$0.00	Acquired	4136387	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1750000	Indirect
Common Stock	1492094	Indirect
Common Stock	709720	Indirect
Common Stock	290280	Indirect
Common Stock	88397	Indirect

Footnotes

F1: Consists of compensatory Restricted Stock Units granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan (the "Plan"). Each compensatory Restricted Stock Unit represents a contingent right to receive one share of the issuer's common stock. One-fourth (1/4th) of the compensatory Restricted Stock Units shall vest on December 21, 2024, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory Restricted Stock Units shall vest each month thereafter, subject to the reporting person continuing to provide services through each such date.

F2: Consists of compensatory Restricted Stock Units granted under the Plan. Each compensatory Restricted Stock Unit represents a contingent right to receive one share of the issuer's common stock. These compensatory Restricted Stock Units are subject to both performance and time-based vesting requirements, subject to the reporting person continuing to provide services through each such date. The performance-based vesting requirements shall be satisfied upon the issuer's stock price trading at or above $6.00 per share for twenty consecutive trading days during a four-year performance period. The time-based vesting requirements shall be satisfied on the same schedule as applies to the time-based awards referenced in footnote (1) above.

F3: Through a grantor retained annuity trust.

F4: Through a family trust controlled by the reporting person's spouse.

F5: Through the reporting person's spouse.

F6: Through a family trust controlled by the reporting person.

F7: Through Clearpoint Strategy Group LLC of which the reporting person is the sole owner.